Skip to main content
Global Arbitration, Trade and Advocacy Update

Buy (More) American: Final Rule Falls Short of Previewed Changes But Still Has Major Implications for Life Sciences and Other Companies

March 28, 2022

On March 7, 2022, the U.S. Department of Defense (DOD), General Services Administration, and National Aeronautics and Space Administration (collectively, the Government) issued an important final rule amending the Buy American Act (BAA) requirements in the Federal Acquisition Regulation (FAR), which will go into effect on October 25, 2022.1 Although the final rule implements some of the proposals first seen in a proposed rule on the same subject published on July 31, 2021, the final rule acknowledges that it leaves much undone. Therefore, we should expect to see more changes — though, even then, all of the considerations highlighted in last year’s proposed rule may not see the light of day for some time, if ever.

The July 30, 2021, proposed rule, in furtherance of President Joe Biden’s January 25, 2021, executive order2 to encourage the use of federal procurements to support American businesses and workers, was intended to significantly strengthen the BAA requirements in the FAR.3 Sidley previously addressed this proposal in detail

The BAA is a standard FAR provision found in many agency procurements, including procurements of pharmaceuticals and medical devices. It is normal for such procurements above the micropurchase threshold of $10,000 to contain either a BAA clause or a Trade Agreements Act (TAA) clause, also discussed below, and each of these clauses establishes country of origin requirements that can strongly affect the Government’s contract award decisions. Consequently, it is important for life sciences companies to understand what will be changing and what will remain the same, at least for the present, regarding these clauses.

To best understand what aspects of the BAA remain as they have been and what are changed, this Alert first addresses the key elements that remain the same.

律师广告—Sidley Austin LLP 是一家全球性律师事务所。我们的地址及联系方式可在 www.sidley.com/en/locations/offices 查阅。

Sidley 提供本信息仅作为向客户及其他友好人士提供的服务,且仅供教育目的使用。本信息不应被解释或依赖为法律意见,亦不构成律师与客户关系。读者在未寻求专业顾问意见之前,不应依据本信息采取任何行动。Sidley 和 Sidley Austin 指 Sidley Austin LLP 及其关联合伙实体,详见 www.sidley.com/disclaimer

© Sidley Austin LLP

联系我们

如果您对本次 Sidley 更新有任何疑问,请联系您平时合作的 Sidley 律师,或